青黄散治疗髓系肿瘤的临床研究进展
Clinical Research Progress of Qinghuang Powder in the Treatment of Myeloid Tumors
邓来军 1董杨 1刘丽娟 1周超 1孙伟国 2孙长岗1
作者信息
- 1. 潍坊市中医院,山东 潍坊 261000
- 2. 安丘海吉亚医院,山东 安丘 262124
- 折叠
摘要
髓系肿瘤(Myeloid neoplasms)是一组异质性疾病,肿瘤细胞起源于骨髓中具有多向分化潜能的造血干细胞,并出现克隆性增殖.从20世纪70年代中期开始,诸多经典中药方剂,临床运用效果明显,而青黄散作为代表,通过大量临床数据证实该方治疗髓系肿瘤有效,为古方中药的发掘与研究提供指引,然而如何将中医的研究成果科学化、全球化,是机遇也是挑战.
Abstract
Myeloid neoplasms are heterogeneous diseases in which myeloid neoplasms are derived from hematopoietic stem cells with the potential for multidifferentiation and clonal proliferation in the bone marrow.Since the mid-1970s,many classical Chinese medicine prescriptions have shown obvious clinical application effects,and Qinghuang SAN,as a representative,has proved its effectiveness in the treatment of myeloid tumors through a large number of clinical data,providing guidance for the dis-covery and research of ancient Chinese medicine.However,how to scientize and globalize the research results of Chinese medi-cine is both an opportunity and a challenge.
关键词
青黄散/髓系肿瘤/传承/发展Key words
qinghuang san/myeloid tumor/inheritance/develop-ment引用本文复制引用
基金项目
国家自然科学基金(82174222)
山东省中医药科技项目(2021M088)
出版年
2024
国家科技期刊平台
NSTL
万方数据